Home » Topics » Regulatory

Regulatory
RSS

Controlled-release tramadol under development

Jan. 20, 1998

Sheffield proceeds with development of respiratory drugs in its MSI

Jan. 20, 1998

Zeneca commits to development of Zomig line extensions

Jan. 20, 1998

Lovenox/Clexane receives approvals in 11 additional countries

Jan. 20, 1998

Cardizem Monovial now available in U.S.

Jan. 19, 1998

Paxene tentatively approved by FDA

Jan. 16, 1998

Connetics to develop clobetasol mousse for dermatoses

Jan. 16, 1998

FDA clears new indication for Rythmol

Jan. 15, 1998

FDA approves first OTC drug for migraine

Jan. 15, 1998

Pivotal trial of PROSORBA column in RA stopped early due to favorable results

Jan. 15, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.